New C. diff Drug OK’d by FDA Panel

An FDA advisory panel recommended approval of Optimer’s fidaxomicin, a desperately needed new treatment for the C. diff superbug. But the panel split over whether Optimer can say the drug prevents C. diff recurrence.

Go here to read the rest:

New C. diff Drug OK’d by FDA Panel

Posted by on April 5, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.